These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28922966)

  • 1. Plasma lipids metabolism in mild cognitive impairment and Alzheimer's disease.
    Costa AC; Joaquim HPG; Forlenza O; Talib LL; Gattaz WF
    World J Biol Psychiatry; 2019 Mar; 20(3):190-196. PubMed ID: 28922966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet phospholipase A(2) activity in Alzheimer's disease and mild cognitive impairment.
    Gattaz WF; Forlenza OV; Talib LL; Barbosa NR; Bottino CM
    J Neural Transm (Vienna); 2004 May; 111(5):591-601. PubMed ID: 15088152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease.
    Torres LL; Quaglio NB; de Souza GT; Garcia RT; Dati LM; Moreira WL; Loureiro AP; de Souza-Talarico JN; Smid J; Porto CS; Bottino CM; Nitrini R; Barros SB; Camarini R; Marcourakis T
    J Alzheimers Dis; 2011; 26(1):59-68. PubMed ID: 21593563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased phospholipase A2 activity in the brain and in platelets of patients with Alzheimer's disease.
    Gattaz WF; Cairns NJ; Levy R; Förstl H; Braus DF; Maras A
    Eur Arch Psychiatry Clin Neurosci; 1996; 246(3):129-31. PubMed ID: 8739397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Metabolomic Analysis of Soluble Lysates from Platelets of Patients with Mild Cognitive Impairment and Alzheimer's Disease Compared to Healthy Controls: Is PC aeC40:4 a Promising Diagnostic Tool?
    Oberacher H; Arnhard K; Linhart C; Diwo A; Marksteiner J; Humpel C
    J Alzheimers Dis; 2017; 57(2):493-504. PubMed ID: 28269764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study.
    Costa AC; Joaquim HPG; Forlenza OV; Gattaz WF; Talib LL
    Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):483-488. PubMed ID: 31218445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relevance of metabolism of membrane phospholipids for Alzheimer dementia].
    Gattaz WF; Levy R; Cairns NJ; Förstl H; Braus DF; Maras A
    Fortschr Neurol Psychiatr; 1996 Jan; 64(1):8-12. PubMed ID: 8850090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease.
    Ouma S; Suenaga M; Bölükbaşı Hatip FF; Hatip-Al-Khatib I; Tsuboi Y; Matsunaga Y
    Brain Behav; 2018 Mar; 8(3):e00936. PubMed ID: 29541546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low platelet iPLA₂ activity predicts conversion from mild cognitive impairment to Alzheimer's disease: a 4-year follow-up study.
    Gattaz WF; Talib LL; Schaeffer EL; Diniz BS; Forlenza OV
    J Neural Transm (Vienna); 2014 Feb; 121(2):193-200. PubMed ID: 24036895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.
    Shen Y; Wang H; Sun Q; Yao H; Keegan AP; Mullan M; Wilson J; Lista S; Leyhe T; Laske C; Rujescu D; Levey A; Wallin A; Blennow K; Li R; Hampel H
    Biol Psychiatry; 2018 Mar; 83(5):447-455. PubMed ID: 28359566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased Levels of Blood AMPKα1 but not AMPKα2 Isoform in Patients with Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Study.
    Wang X; Zimmermann HR; Lockhart SN; Craft S; Ma T
    J Alzheimers Dis; 2020; 76(1):217-224. PubMed ID: 32444538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects.
    Forlenza OV; Miranda AS; Guimar I; Talib LL; Diniz BS; Gattaz WF; Teixeira AL
    J Alzheimers Dis; 2015; 46(2):423-9. PubMed ID: 25737042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Phosphatidylethanolamine and Lysophosphatidylethanolamine Levels Differentiate Alzheimer's Disease from Controls and Predict Progression from Mild Cognitive Impairment.
    Llano DA; Devanarayan V;
    J Alzheimers Dis; 2021; 80(1):311-319. PubMed ID: 33523012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Homocysteine and Serum Folate and Vitamin B
    Ma F; Wu T; Zhao J; Ji L; Song A; Zhang M; Huang G
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28698453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma protein profiling of mild cognitive impairment and Alzheimer's disease across two independent cohorts.
    Muenchhoff J; Poljak A; Song F; Raftery M; Brodaty H; Duncan M; McEvoy M; Attia J; Schofield PW; Sachdev PS
    J Alzheimers Dis; 2015; 43(4):1355-73. PubMed ID: 25159666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet Total PLA
    Balietti M; Casoli T; Giacconi R; Giuli C
    Rejuvenation Res; 2022 Feb; 25(1):16-24. PubMed ID: 34913745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum tumour necrosis factor-α and interleukin-6 levels in Alzheimer's disease and mild cognitive impairment.
    Kim YS; Lee KJ; Kim H
    Psychogeriatrics; 2017 Jul; 17(4):224-230. PubMed ID: 28130814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Searching for predictive blood biomarkers: misfolded p53 in mild cognitive impairment.
    Stanga S; Lanni C; Sinforiani E; Mazzini G; Racchi M
    Curr Alzheimer Res; 2012 Dec; 9(10):1191-7. PubMed ID: 22746246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer's disease patients.
    Talib LL; Hototian SR; Joaquim HP; Forlenza OV; Gattaz WF
    Eur Arch Psychiatry Clin Neurosci; 2015 Dec; 265(8):701-6. PubMed ID: 25920742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.